Get started
Author

Shuvadeep Ganguly

Observed name: Ganguly, Shuvadeep
ORCID: 0000-0002-7296-6088
Observed ORCID: 0000-0002-7296-6088
OpenAlex ID: A5127995213
Assessing the Impact of Rituximab on Treatment Outcomes in Pediatric Advanced Mature B-Non Hodgkin Lymphoma
2026 · Ekta Rahul, Archana Sasi, et al. · The Indian Journal of Pediatrics · 3
Intravenous Fosaprepitant Versus Oral Aprepitant for Children Receiving Highly Emetogenic Chemotherapy: An Investigator‐Initiated Randomized, Open‐Label, Non‐Inferiority Trial
2026 · Azgar Abdul Rasheed, Shuvadeep Ganguly, et al. · Pediatric Blood & Cancer · 2
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study
2025 · Swetambri Sharma, Shuvadeep Ganguly, et al. · JMIR Research Protocols · 1
Efficacy and safety of immunotherapy in driver mutation-negative advanced non-small cell lung cancer: A systematic review and meta-analysis
2026 · Jogender Kumar, Shuvadeep Ganguly, et al. · The Indian Journal of Medical Research
PDF
Mitophagy-driven prognosis in pediatric acute myeloid leukemia: a new frontier
2026 · Rajiv Ranjan Kumar, Uttam Sharma, et al. · Scientific Reports
PDF
Works count: 6
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type